BioTime Appoints Franklin Berger to Board of Directors

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

BioTime, Inc. (NYSE MKT: BTX) today announced that Franklin M. Berger, CFA, 63, has been appointed to its Board of Directors.

“We are pleased to welcome a recognized biotechnology industry expert of Franklin’s caliber to BioTime’s Board,” said Alfred D. Kingsley, Chairman of the Board of BioTime.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC